Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12124
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarvill, Gemma Len
dc.contributor.authorWeckhuysen, Sarahen
dc.contributor.authorMcMahon, Jacinta Men
dc.contributor.authorHartmann, Corinnaen
dc.contributor.authorMøller, Rikke Sen
dc.contributor.authorHjalgrim, Helleen
dc.contributor.authorCook, Josephen
dc.contributor.authorGeraghty, Eileenen
dc.contributor.authorO'Roak, Brian Jen
dc.contributor.authorPetrou, Stevenen
dc.contributor.authorClarke, Alisonen
dc.contributor.authorGill, Deepak Sen
dc.contributor.authorSadleir, Lynette Gen
dc.contributor.authorMuhle, Hiltruden
dc.contributor.authorvon Spiczak, Sarahen
dc.contributor.authorNikanorova, Marinaen
dc.contributor.authorHodgson, Bree Len
dc.contributor.authorGazina, Elena Ven
dc.contributor.authorSuls, Arviden
dc.contributor.authorShendure, Jayen
dc.contributor.authorDibbens, Leanne Men
dc.contributor.authorDe Jonghe, Peteren
dc.contributor.authorHelbig, Ingoen
dc.contributor.authorBerkovic, Samuel Fen
dc.contributor.authorScheffer, Ingrid Een
dc.contributor.authorMefford, Heather Cen
dc.date.accessioned2015-05-16T01:46:24Z
dc.date.available2015-05-16T01:46:24Z
dc.date.issued2014-03-12en
dc.identifier.citationNeurology 2014; 82(14): 1245-53en
dc.identifier.govdoc24623842en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12124en
dc.description.abstractTo determine the genes underlying Dravet syndrome in patients who do not have an SCN1A mutation on routine testing.We performed whole-exome sequencing in 13 SCN1A-negative patients with Dravet syndrome and targeted resequencing in 67 additional patients to identify new genes for this disorder.We detected disease-causing mutations in 2 novel genes for Dravet syndrome, with mutations in GABRA1 in 4 cases and STXBP1 in 3. Furthermore, we identified 3 patients with previously undetected SCN1A mutations, suggesting that SCN1A mutations occur in even more than the currently accepted ∼ 75% of cases.We show that GABRA1 and STXBP1 make a significant contribution to Dravet syndrome after SCN1A abnormalities have been excluded. Our results have important implications for diagnostic testing, clinical management, and genetic counseling of patients with this devastating disorder and their families.en
dc.language.isoenen
dc.subject.otherAdolescenten
dc.subject.otherAdulten
dc.subject.otherChilden
dc.subject.otherChild, Preschoolen
dc.subject.otherEpilepsies, Myoclonic.geneticsen
dc.subject.otherFemaleen
dc.subject.otherGenetic Predisposition to Disease.geneticsen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMunc18 Proteins.geneticsen
dc.subject.otherMutation.geneticsen
dc.subject.otherNerve Tissue Proteins.geneticsen
dc.subject.otherReceptors, GABA-A.geneticsen
dc.subject.otherYoung Adulten
dc.titleGABRA1 and STXBP1: novel genetic causes of Dravet syndrome.en
dc.typeJournal Articleen
dc.identifier.journaltitleNeurologyen
dc.identifier.affiliationand the Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Australiaen
dc.identifier.affiliationDepartment of Paediatrics (L.G.S.), School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand; Epilepsy Research Program (B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, University of South Australia, Adelaide; Division of Neurology (P.D.J.), Antwerp University Hospital, Belgiumen
dc.identifier.affiliationEpilepsy Centre Kempenhaeghe (S.W.), Oosterhout, the Netherlands; Epilepsy Research Centre (J.M.M., S.F.B., I.E.S.), Department of Medicine, University of Melbourne, Austin Health, Australiaen
dc.identifier.affiliationFrom the Division of Genetic Medicine, Department of Pediatrics (G.L.C., C.H., J.C., E.G., H.C.M.), and the Department of Genome Sciences (J.S.), University of Washington, Seattle; Neurogenetics Group (S.W.), Department of Molecular Genetics, VIB, Antwerp; Laboratory of Neurogenetics (S.W., A.S., P.D.J.), Institute Born-Bunge, University of Antwerp, Belgiumen
dc.identifier.affiliationDanish Epilepsy Centre (R.S.M., H.H., M.N.), Dianalund; Institute for Regional Health Services (H.H., M.N.), University of Southern Denmark, Odense, Denmark; Department of Molecular and Medical Genetics (B.J.O.), Oregon Health and Science University, Portland; Florey Institute (S.P., A.C., E.V.G., I.E.S.), Victoria; TY Nelson Department of Neurology (D.G.), The Children's Hospital at Westmead, Sydney, NSW, Australiaen
dc.identifier.affiliationDepartment of Neuropediatrics (C.H., H.M., S.v.S., I.H.), University Medical Center, Schleswig-Holstein, Christian-Albrechts University, Kiel, Germanyen
dc.identifier.doi10.1212/WNL.0000000000000291en
dc.description.pages1245-53en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/24623842en
dc.type.austinJournal Articleen
local.name.researcherBerkovic, Samuel F
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptNeurology-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Nov 8, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.